Category Archives: Cancer Research

Cancer Research, Testimonials

Mexican Research Supports Alternative Cancer Treatment for Lung Cancer

2 Comments
Alternative Lung Cancer Treatment
Alternative Lung Cancer Treatment

New lung cancer research being conducted in Mexico appears to parallel alternative cancer treatments developed by Issels Integrative Oncology and in use at our Alternative Cancer Treatment Centers for years. According to EurasiaReview.com, researchers at Mexico’s National Institute of Respiratory Diseases are working on developing a lung cancer treatment that would use the patient’s own blood to boost immune system function. We are naturally pleased to see other cancer researchers following in our footprints.

A key component of our well-established integrative immunotherapy cancer treatment program, Issels’ cutting-edge, non-toxic autologous cancer vaccines are cultured from the patient’s own blood. Using the patient’s blood both maximizes immune system response and, because nothing foreign is being introduced into the body, removes the issue of toxicity that creates so many problems for chemotherapy and radiation patients.

“We are developing at the lab a system of cell activation from the patient’s own blood so it can eliminate its tumors,” the institute’s lead researcher, Patricia Gorocica, told Eurasia Review. Gorocica and her team are part of a growing movement in Western medicine that now shares our view that the future of cancer treatment lays within the body’s immune system. For more than 60 years, Issels has been a leader in the use of individualized immunotherapy to fight cancer. It is gratifying to find increasing recognition of our core treatment values.

The Institute’s push for new lung cancer treatments has been spurred by an uptick in worldwide lung cancer rates which researchers believe may be related as much to increased pollution particulate and smoke from burning timber and coal as cigarette smoking, particularly in developing countries.

For more information on autologous cancer vaccines alternative cancer treatments, and supporting research, visit our website.

Cancer Research, Uncategorized

WHO Predicts Worldwide Cancer Increase

Cancer Research
Cancer Research

Researchers are making progress in combating cancer, particularly in the United States and other industrialized nations where medical treatment is readily available. But in the rest of the world, cancer is on the rise, according to a new report by the World Health Organization (WHO). As developing countries adopt modern lifestyles, cancer rates are increasing. According to WHO, cancer cases worldwide could surpass 19 million by 2025.

Between 2008 and 2012, cancer diagnoses worldwide grew from 12.7 million to more than 14 million and deaths from cancer rose from 7.6 to 8.2 million. By the end of the next decade, WHO expects the number of people diagnosed with cancer to begin approaching the 20 million mark, which would be a significant jump over the current worldwide cancer growth rate.

As developing countries become more industrialized, smoking, obesity and longer life spans are contributing to an increased risk of cancer, according to a BBC News health report. Lung cancer, primarily from cigarette smoking, poses the greatest risk, accounting for 13% of total cancer cases, or about 1.8 million diagnoses, worldwide. WHO also cited a significant rise in the global number of breast cancer cases; noting that breast cancer has become the most common cancer among women in 140 countries.

“Breast cancer is also a leading cause of cancer death in the less developed countries of the world. This is partly because a shift in lifestyles is causing an increase in incidence and partly because clinical advances to combat the disease are not reaching women living in these regions,” Dr. David Forman of WHO’s International Agency for Research told BBC News.

Alternative Cancer Treatment, Cancer Research

Spermbots: The Future of Targeted Cancer Treatment?

Alternative Cancer Treatments
Alternative Cancer Treatments

One of the greatest challenges in targeted cancer therapy is achieving accurate delivery of the beneficial agent directly to the cancer cells you wish to affect. Researchers at the Institute for Integrative Nanoscience in Dresden, Germany are working on a novel solution to the problem. They are attempting to turn sperm cells into cancer treatment delivery agents.

The Germans were trying to build biobots, microscopic robots that could be controlled and directed from outside the body while surviving inside the body without damaging or being rejected by their host. After experimenting with numerous biologic materials, Discover Magazine recently reported that the researchers found a winner in sperm – specifically, the sperm from bulls (yes, the farm animal).

Strong and agile, modified sperm, called “spermbots” by the Germans, were able to deliver the propulsion the scientists desired. The ability to direct the sperm cells’ movement was achieved by exposing the sperm cells to a magnetic field in the laboratory and then using magnets to provide directional guidance. As explained in Discover Magazine, “It’s like a remote-control robot where the sperm start the engines and the researchers provide the navigation.”

While the research appears to have the greatest immediate potential for developing an in vivo, or inside the body, alternative to in vitro fertilization; the German scientists believe that human sperm cells could someday be used to deliver medicine and other beneficial agents directly to the body’s cells, potentially opening a new pathway for the delivery of advanced targeted cancer therapies. Even more boldly, they imagine a day when spermbots might be directed to “drill” into cancerous cells and actually cure cancer!

Alternative Cancer Treatment, Cancer Research

New Study: Many U.S. Lung Cancer Patients Are Undergoing Unnecessary Treatment

Lung Cancer
Lung Cancer

Lung cancer is the leading cause of cancer death in the U.S. for both men and women, killing more than 150,000 people a year. According to the American Lung Association, lung cancer is responsible for 28% of all cancer deaths, surpassing the combined fatality rate of the next three most common cancers: colon, breast and prostate cancer.

The high threat of fatality has made aggressive treatment of all lung cancers standard practice in the United States. A new study that is being labeled “provocative,” by the American press, indicates that many lung cancer patients have endured painful surgery, chemotherapy and radiation needlessly. According to the Duke University Medical Center study, nearly 1 in 5 lung tumors detected by CT scans are too slow-growing to warrant treatment, much less the radical treatment that has become standard procedure among practitioners of Western medicine.

As Dr. Len Litchtenfeld of the National Cancer Institute explained to USA Today, the Duke study suggests that for every 10 lives saved by CT lung cancer screening, about 14 people will have been diagnosed with a lung cancer that does not require radical treatment. What that means is that 3 out of every 5 people diagnosed with lung cancer are likely to suffer through the pain, suffering, worry and expense of cancer surgery, chemotherapy and/or radiation treatments that may be unnecessary.

For patients with slow-growing lung cancers, the study suggests that refusing to undergo invasive treatments would not alter the patient’s health or life expectancy in any noticeable way. Integrated immunotherapy offers many lung cancer patients a welcome, non-toxic treatment option. Visit our website to find out more about our non-toxic cancer treatments.

Alternative Cancer Treatment, Cancer Research

Gene Therapy Shows ‘Unprecedented Success’ Against Blood Cancers

Gene Therapy
Gene Therapy

Advanced genetically-targeted treatments are proving to be remarkably successful against leukemia and other blood cancers. Here’s what the Associated Press had to say:

“In one of the biggest advances against leukemia and other blood cancers in many years, doctors are reporting unprecedented success by using gene therapy to transform patients’ blood cells into soldiers that seek and destroy cancer.”

In tests by six different research groups, blood cancer patients who received gene therapy showed survival rates that researchers called “stunning.” In one study, all but three of the 27 patients with acute lymphocytic leukemia achieved complete remission with targeted genetic therapy. While a few of those patients have since relapsed, the therapy success rate remains impressive.

Before undergoing genetic immunotherapy, these leukemia patients had undergone chemotherapy and stem cell or bone-marrow transplants without success. If additional tests achieve similar results, researchers believe eventual approval by the U.S. Food & Drug Administration may be possible.

The gene therapy that has the U.S. research community cheering involves a blood filtering process that removes T-cells from the patient’s blood, adds a targeting gene and returns the cells to the patient by transfusion. Called “a living drug” by researchers, the altered T-cells multiply in patient’s body, strengthening the patient’s immune response and ability to fight cancer.

While being heralded by traditional Western medical practitioners as “new,” Issels , an alternative cancer treatment center, has been using similar advanced genetically-targeted cancer therapies as part of our individualized integrative immunotherapy program for years. Our non-toxic autologous vaccine program employs a similar blood transfusion mechanism to boost the body’s immune system response.

Cancer Research, Immunotherapy

Immune Cells May Hold Key to Brain Cancer Treatment

Immune Cells
Immune Cells

The immune system is your body’s natural protective force. When cancer cells develop or when foreign substances invade your body, your immune system goes on the attack, sending specialized cells to target these “foreign” invaders.

Highly specialized immune system cells called microglia protect the brain. While examining brain cancer tumors in diseased mice, Canadian researchers found deactivated microglia. When these cells were reactivated, the mice lived two to three times longer than untreated mice with the same type of brain tumor.

A joint effort by research teams at the University of Calgary Hotchkiss Brain Institute and Southern Alberta Cancer Research Institute, the discovery may eventually lead to new immunotherapy treatments for brain cancer, although researchers say additional research is needed before clinical trials can be contemplated. The Canadian study focused on glioblastoma tumors, the deadliest form of brain cancer. Fifteen months is the median survival rate for glioblastoma patients. Even with currently available treatments, fewer than one in 20 pass the five-year survival mark.

In Medical News Today (MNT), study author V. Wee Yong, who holds a Canada Research Chair in Neuroimmunology, explained that inactivated microglia are a normal result of the battle between immune cells and cancer cells. Over time, aggressive tumor cells can overwhelm the brain’s immune system, deactivating its defender cells. Reactivating these cells can “tip the battle in favor of the brain to suppress the tumor,” Yong said.

The Canadians used a highly caustic drug to restore function to the brain’s immune cells. Issels cancer treatments strengthen and enhance immune system function using non-toxic integrated immunotherapy to avoid the destructive side effects of harsh drugs.